Sep 13 |
Moderna's Pain Continues Amid Flurry Of Downgrades Following 'Tough' R&D Day
|
Sep 13 |
Moderna Stock Keeps Falling. An Analyst's Downgrade Isn't Helping
|
Sep 13 |
MRNA Stock Falls 12% on Lowered Sales Outlook, R&D Budget Cuts
|
Sep 13 |
Midday stock movers: Adobe, Boeing, Moderna
|
Sep 13 |
Moderna's Faces 'Material Headwinds' on RSV, COVID, RBC Says
|
Sep 13 |
Moderna continues to decline as Oppenheimer latest to downgrade
|
Sep 13 |
Moderna's Move Shows Lack Of Confidence, Shrinks Pipeline
|
Sep 13 |
Moderna: Looking For The Bottom
|
Sep 13 |
Moderna stock slides on downgrades tied to profitability delay
|
Sep 13 |
Moderna, Halliburton downgraded: Wall Street's top analyst calls
|